Table 6 summarizes the risk estimates for individuals in each terminal node. Node 1 (N = 101), used for reference, had the lowest risk and comprised of patients who were GG for rs11250080 on PINX1, TC/CC for rs1469557 on PINX1, and AA for rs2228041 on TEP1. Compared to individuals in node 1, the other nodes were associated with increased bladder cancer risk with ORs ranging from 1.74 to 3.28 based on distinct genotype combinations. Individuals in node 5 (N = 177) with AG/GG for rs2228041 on TEP1 had the highest risk (OR 3.28, 95% CI 1.94–5.57). This evidence concerns the gene PINX1 and urinary bladder carcinoma.